Multi‐center survey regarding the management of anticoagulation and antiplatelet therapy for endoscopic procedures in Japan

Background:  A guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures has been established from Japan Gastroenterological Endoscopy Society in 2005. However, it is unknown whether consensus on the management of these conditions is obtained among endoscopists in daily practice owing to the guideline.

[1]  D. Rockey,et al.  Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. , 2008, Gastrointestinal endoscopy.

[2]  A. Gershlick,et al.  Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures , 2008, Gut.

[3]  Kiichi Sato,et al.  Management of anticoagulation and antiplatelet therapy in endoscopic procedures , 2008 .

[4]  A. Munakata,et al.  MANAGEMENT OF ANTIPLATELET THERAPY FOR ENDOSCOPIC PROCEDURES: OPTIMAL CESSATION PERIOD OF ANTIPLATELET THERAPY FOR JAPANESE , 2007 .

[5]  S. Heitman,et al.  Management of anticoagulants and antiplatelet agents in elective endoscopy: weighing the risks and benefits. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[6]  H. Osman,et al.  National survey of anticoagulation policy in endoscopy , 2007, European journal of gastroenterology & hepatology.

[7]  A. Munakata,et al.  A SURVEY OF THE RELATIONSHIP BETWEEN THE CESSATION PERIOD OF ANTI-PLATELET AGENTS ON THE INVASIVE ENDOSCOPIC PROCEDURE , 2006 .

[8]  C. Samama,et al.  Guidelines of the French Society for Digestive Endoscopy (SFED) , 2006, Endoscopy.

[9]  A. Munakata,et al.  Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures , 2005, Journal of Gastroenterology.

[10]  D. Faigel,et al.  ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. , 2005, Gastrointestinal endoscopy.

[11]  R. Kiesslich,et al.  Current practice in managing patients on anticoagulants and/or antiplatelet agents around the time of gastrointestinal endoscopy -- a nation-wide survey in Germany. , 2004, Zeitschrift fur Gastroenterologie.

[12]  K. Togashi,et al.  HOW ANTIPLATELETS AND ANTICOAGULANTS SHOULD BE MANAGED IN ENDOSCOPIC TREATMENT , 2004 .

[13]  D. Blacker,et al.  Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy , 2003, Neurology.

[14]  M. Bell,et al.  Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. , 2002, Journal of the American College of Cardiology.

[15]  D. Faigel,et al.  Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. , 2002, Gastrointestinal endoscopy.

[16]  M. Bassett,et al.  Anticoagulant therapy, anti‐platelet agents and gastrointestinal endoscopy , 1999, Journal of gastroenterology and hepatology.

[17]  S. Pocock,et al.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. , 1999, The New England journal of medicine.

[18]  S. Pocock,et al.  A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting , 1998 .

[19]  S. Kadakia,et al.  Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: survey of ASGE members , 1996 .

[20]  C. Gostout,et al.  The risk of withdrawing chronic anticoagulation because of acute GI bleeding. , 1996, The American journal of gastroenterology.